Willow Biosciences Inc
TSX:WLLWView on OTCQB

  • LAST PRICE
    0.0800
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0800 / 0.0800
  • Day Range
    0.0800
    0.0800
  • 52 Week Range
    0.0700
    0.1500
  • Volume
    56,250

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
WLLW
Willow Biosciences Inc
11.5M
-1.3x
---
IOT
Innovotech Inc
7.2M
-18.7x
---
HEM
Hemostemix Inc
10.5M
-4.0x
---
BETR
BetterLife Pharma Inc
13.6M
-2.9x
---
TELO
Telo Genomics Corp
8.6M
-3.2x
---
XRTX
XORTX Therapeutics Inc
5.5M
-37.3x
---
As of 2024-11-22

Company Information

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

Contact Information

Headquarters
202, 1201 5th Street SWCALGARY, AB, Canada T2R 0Y6
Phone
403-910-5140
Fax
403-669-4848

Executives

Independent Chairman of the Board
James Lalonde
President, Chief Executive Officer, Director
Chris Savile
Chief Financial Officer
Travis Doupe
Senior Vice President - Research and Development
Trish Choudhary
Corporate Secretary
Sanjib Gill

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$11.5M
Revenue (TTM)
$2.9M
Shares Outstanding
144.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.14
EPS
$-0.06
Book Value
$0.03
P/E Ratio
-1.3x
Price/Sales (TTM)
4.0
Price/Cash Flow (TTM)
---
Operating Margin
-251.83%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.